2018: Briefing note on NIH proposed license to Gilead for CD-30 CAR T technology

Contact: Kim Treanor 202-332-2670; kim.treanor@keionline.org January 5, 2018 The National Institutes of Health (NIH) has proposed an exclusive license with Gilead for certain patent applications for inventions that target CD-30 proteins and CAR T technologies. The proposed license is to… Continue Reading

Walgreen and Kroger sue Johnson & Johnson over Remicade, Allege Antitrust Violation

Walgreen and Kroger, two major U.S. pharmacies, have filed suit against Johnson & Johnson in the U.S. District Court Eastern District of Pennsylvania, alleging antitrust violations stemming from exclusionary contracts and rebates designed to prevent biosimilars of J&J’s Remicade (INN:… Continue Reading

WHA71: KEI statement on the Draft thirteenth general programme of work, 2019–2023

At the 71st World Health Assembly, KEI will deliver the following intervention regarding the Draft thirteenth general programme of work, 2019–2023. Strategic priority matters 11.1 Draft thirteenth general programme of work, 2019–2023 KEI endorses the WHO’s unwavering commitment to universal… Continue Reading

WHA71: KEI intervention on the Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 2018

At the 71st World Health Assembly, KEI will deliver the following intervention regarding the Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 2018. 11.7 Preparation for… Continue Reading

WHA71: KEI intervention on Global strategy and plan of action on public health, innovation and intellectual property

At the 71st World Health Assembly, KEI will deliver the following intervention regarding the Global Strategy and Plan of Action on Public Health, Innovation, and Intellectual Property: 11.6 Global strategy and plan of action on public health, innovation and intellectual… Continue Reading

WHA71: KEI intervention on Addressing the global shortage of, and access to, medicines and vaccines

21 May 2018 Knowledge Ecology International (KEI) intends to deliver the following statement on Addressing the global shortage of, and access to, medicines and vaccines. 11.5 Addressing the global shortage of, and access to, medicines and vaccines Documents A71/12 and… Continue Reading

Rep Doggett amendment proposed the use of 28 USC 1498 in negotiations for affordable treatments to reverse opioid overdoses

On Wed, May 16, 2018, the House Ways & Means Committee held a markup on HR. 5773, a bill dealing with the opioid crisis, which would require Medicare prescription drug plans to establish drug management programs for at-risk beneficiaries. Representative… Continue Reading